Results 241 to 250 of about 92,046 (305)

Hydrogel-based formulations for urothelial cancer therapy. [PDF]

Front Pharmacol
Chang M, Chi C, Zheng Z, Zhang M, Lv J, Wang X.   +5 more
europepmc   +1 more source

Plain language summary of the THOR Cohort 1 study comparing treatment with erdafitinib or chemotherapy in advanced or metastatic urothelial cancer. [PDF]

Future Oncol
Loriot Y, Triantos S, Deprince K, Siefker-Radtke AO.   +3 more
europepmc   +1 more source

A multiregional study of presentation and outcomes in upper tract urothelial cancer: Data from East Asia and Europe. [PDF]

Asian J Urol
Chiu TH, Wei TC, Miki J, Teoh JY, Yee CH, Yuk HD, Cho SY, Kramer MW, Ho PS, Huang YT, Lee HY.   +10 more
europepmc   +1 more source

Enfortumab vedotin and pembrolizumab: redefining the standard of care for previously untreated advanced urothelial cancer. [PDF]

Future Oncol
Sternschuss M, Rosenberg JE.
europepmc   +1 more source

Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring.

JAMA Netw Open
Meirson T, Ofer J, Zimhony-Nissim N, Bareket-Samish A, Markel G, Neiman V, Cherny N, Goldstein DA, Gyawali B, Tannock I, Rosenbaum E.   +10 more
europepmc   +1 more source